Corporate Updates Received tentative approval from the FDA for YUTREPIA (treprostinil) inhalation powder In August, the FDA granted tentative approval for YUTREPIA for the treatment of patients with ...
The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
November is Pulmonary Hypertension Awareness Month, and George Washington University Hospital’s Doctor Mardi Gomberg-Maitland ...
The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
During a Case-Based Roundtable® event, Lori J. Wirth, discussed the SELECT trial and the role of multikinase inhibitors in ...
The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...
Dr. Madhu Pamganamamula, the Medical Director for the Center for Hypertension & Internal Medicine, in Odessa, has ...
A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and hands may offer a new way to screen ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Popular videos and social media posts have identified cortisol as the main culprit behind facial puffiness, but many ...
Men were more likely than women to have high blood pressure, federal officials found, but men were also less likely than women to know they had hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback